WHO (World Health Organization) has just published in its virtual library “COVID-19 – Global literature on coronavirus disease” three papers on Ozone Saline Solution, a route of application of ozone therapy, as a complementary therapy, and COVID-19.
(1) Complementary application of the ozonized saline solution in mild and severe patients with pneumonia COVID-19: A non-randomized pilot study
Schwartz, A .; Martínez-Sánchez, G .; de Lucía, A. M .; Viana, S. M .; Constanta, A. M. Journal of Pharmacy and Pharmacognosy Research; 9 (2): 126-146, 2021.
Article | WHO COVID | ID: covidwho-984802
The research was carried out in mild and severe patients hospitalized for COVID-19 at the Viamed Virgen de la Paloma Hospital in Madrid (Spain). It yielded very positive and quick results, using the Ozone Saline Solution – an application route of ozone therapy, as complementary therapy.
Access to full article https://jppres.com/jppres/pdf/vol9/jppres20.971_9.2.126.pdf
(2) Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2 / COVID-19.
Martínez-Sánchez, Gregorio; Schwartz, Adriana; Donna, Vincenzo Di.
Antioxidants (Basel); 9 (5) 2020 May 06.Article in English | MEDLINE | ID: covidwho-854062
The scientific journal where this paper has been published has an impact level 5.014, H index 33
Cite Score 3.7. For an article in support of the medical use of ozone, this is the published article with the highest impact index.
(3) Potential use of ozone in SARS-CoV-2 / COVID-19
Non-conventional | Grey literature | ID: grc-743616
Access to full article in eight languages https://isco3.org/officialdocs/
This content is also available in: Spanish